July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Near-infrared Autofluoresence Imaging in Choroideremia
Author Affiliations & Notes
  • Maarjaliis Paavo
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Winston Lee
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Jesse Sengillo
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Stephen H Tsang
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Janet R Sparrow
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Maarjaliis Paavo, None; Winston Lee, None; Jesse Sengillo, None; Stephen Tsang, None; Janet Sparrow, None
  • Footnotes
    Support  NIH EY012951, EY024091 and a grant RPBI CU50805912 from RPB to Department of Ophthalmology, Columbia University
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4664. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maarjaliis Paavo, Winston Lee, Jesse Sengillo, Stephen H Tsang, Janet R Sparrow; Near-infrared Autofluoresence Imaging in Choroideremia. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4664.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : This study analyzes the disease characteristics of choroideremia (CHM) across several imaging modalities including near-infrared autofluoresence (NIR-AF) images acquired from choroideremia patients and CHM carriers. Our aim was to better understand the degenerative process and changes in the retina.

Methods : A cross-sectional analysis of retinal imaging data was performed on patients diagnosed with CHM (n=10) along with heterozygous female carriers (n=5). Disease-causing mutations in REP1 were confirmed in all subjects by direct sequencing. Principal outcome measures included near-infrared (787-nm excitation, NIR-AF) and short wavelength (488-nm excitation, SW-AF) autofluorescence images that were acquired on a confocal scanning laser ophthalmoloscope. In addition, macula-centered volume spectral domain-optical coherence tomography (SD-OCT) scans were analyzed.

Results : The CHM probands exhibited characteristic widespread chorioretinal degeneration with residual islands of relatively preserved retina and visual function. Islands that were homogenously hyperautofluorescent on SW-AF were also visibly autofluorescent on corresponding NIR-AF images (Group 1 phenotype, 8/20 eyes); however islands that exhibited a granular, reduced autofluorescent appearance on SW-AF were less discernable on NIR-AF (Group 2 phenotype, 12/20 eyes).
Heterozygous CHM carriers exhibited diffuse patches of RPE atrophy on fundoscopy which corresponded to hypoautofluorescent patches on NIR-AF. Corresponding atrophic patches on SW-AF images were less pronounced. Hyperautofluorescent foci were also observed on NIR-AF imaging.

Conclusions : The preserved retinal islands in CHM patients can present differently in NIR-AF versus SW-AF images. Ablation of the NIR-AF signal in the presence of SW-AF signal could reveal the extent of RPE layer degeneration and loss of melanin relative to photoreceptors. In CHM carriers the atrophic areas were usually more pronounced on NIR-AF than SW-AF imaging. NIR-AF could be a useful imaging modality in disease assessment.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×